NCT00074490 · MORE INFO

Limitations, agreements, and source contact

Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers · Source last updated 2018-12-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee: false
restrictive Agreement: false

limitations And Caveats

description: 118 subjects were enrolled on this study on cohorts no longer represented in the protocol due to amendments. Of the 118, 50% were participants and 50% were donors. These participants are not represented in the data being reported.

point Of Contact

email: steven_pavletic@nih.gov
organization: National Cancer Institute
phone: 301-402-4899
title: Dr. Steven Pavletic

Complete source fields

certain Agreement

pi Sponsor Employee: false
restrictive Agreement: false

limitations And Caveats

description: 118 subjects were enrolled on this study on cohorts no longer represented in the protocol due to amendments. Of the 118, 50% were participants and 50% were donors. These participants are not represented in the data being reported.

point Of Contact

email: steven_pavletic@nih.gov
organization: National Cancer Institute
phone: 301-402-4899
title: Dr. Steven Pavletic

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice